<unk> , originally marketed as Parlodel and subsequently under many<unk> and names, is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and, as an adjunct, type 2 diabetes. It was patented in 1968 and approved for medical use in 1975.
Bromocriptine
Tropisetron
Sertindole
Granisetron
Iobitridol
Agomelatine
Carbidopa/levodopa
Cilansetron